Evaluating Longitudinal Associations between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the CARDIA Study

Allison J. Carroll, Mark D. Huffman, Lihui Zhao, David R Jacobs Jr, Jesse C. Stewart, Catarina I. Kiefe, Kiang Liu, Brian Hitsman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. Methods In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. Results The sample was 56% women, 47% black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's >.01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p =.004) and increasing depressive symptoms (β = 1.36, p <.001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p =.001), soluble intercellular adhesion molecule 1 (β = 24.98, p <.001), and soluble P-selectin (β = 2.91, p <.001). Conclusions Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.

Original languageEnglish (US)
Pages (from-to)372-379
Number of pages8
JournalPsychosomatic medicine
Volume81
Issue number4
DOIs
StatePublished - May 1 2019

Fingerprint

Cardiovascular Diseases
Biomarkers
Smoking
Depression
Epidemiologic Studies
F2-Isoprostanes
Tobacco Products
Oxidative Stress
P-Selectin
Intercellular Adhesion Molecule-1
Inflammation
C-Reactive Protein
Superoxide Dismutase
Young Adult
Linear Models
Coronary Vessels
Chronic Disease
Regression Analysis

Keywords

  • Cardiovascular disease
  • depression
  • endothelial dysfunction
  • inflammation
  • oxidative stress
  • smoking

PubMed: MeSH publication types

  • Journal Article

Cite this

Evaluating Longitudinal Associations between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the CARDIA Study. / Carroll, Allison J.; Huffman, Mark D.; Zhao, Lihui; Jacobs Jr, David R; Stewart, Jesse C.; Kiefe, Catarina I.; Liu, Kiang; Hitsman, Brian.

In: Psychosomatic medicine, Vol. 81, No. 4, 01.05.2019, p. 372-379.

Research output: Contribution to journalArticle

Carroll, Allison J. ; Huffman, Mark D. ; Zhao, Lihui ; Jacobs Jr, David R ; Stewart, Jesse C. ; Kiefe, Catarina I. ; Liu, Kiang ; Hitsman, Brian. / Evaluating Longitudinal Associations between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the CARDIA Study. In: Psychosomatic medicine. 2019 ; Vol. 81, No. 4. pp. 372-379.
@article{351f17647bc94ffa937d44dc366be429,
title = "Evaluating Longitudinal Associations between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the CARDIA Study",
abstract = "Objective The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. Methods In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. Results The sample was 56{\%} women, 47{\%} black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's >.01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p =.004) and increasing depressive symptoms (β = 1.36, p <.001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p =.001), soluble intercellular adhesion molecule 1 (β = 24.98, p <.001), and soluble P-selectin (β = 2.91, p <.001). Conclusions Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.",
keywords = "Cardiovascular disease, depression, endothelial dysfunction, inflammation, oxidative stress, smoking",
author = "Carroll, {Allison J.} and Huffman, {Mark D.} and Lihui Zhao and {Jacobs Jr}, {David R} and Stewart, {Jesse C.} and Kiefe, {Catarina I.} and Kiang Liu and Brian Hitsman",
year = "2019",
month = "5",
day = "1",
doi = "10.1097/PSY.0000000000000667",
language = "English (US)",
volume = "81",
pages = "372--379",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Evaluating Longitudinal Associations between Depressive Symptoms, Smoking, and Biomarkers of Cardiovascular Disease in the CARDIA Study

AU - Carroll, Allison J.

AU - Huffman, Mark D.

AU - Zhao, Lihui

AU - Jacobs Jr, David R

AU - Stewart, Jesse C.

AU - Kiefe, Catarina I.

AU - Liu, Kiang

AU - Hitsman, Brian

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Objective The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. Methods In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. Results The sample was 56% women, 47% black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's >.01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p =.004) and increasing depressive symptoms (β = 1.36, p <.001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p =.001), soluble intercellular adhesion molecule 1 (β = 24.98, p <.001), and soluble P-selectin (β = 2.91, p <.001). Conclusions Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.

AB - Objective The aim of the study was to evaluate associations between 15-year trajectories of co-occurring depressive symptoms and smoking with biomarkers of cardiovascular disease at year 15. Methods In the Coronary Artery Risk Development in Young Adults study, we modeled trajectories of depressive symptoms (Center for Epidemiologic Studies-Depression scale [CES-D]) and smoking (cigarettes per day [CPD]) among 3614 adults followed from year 0 (ages 18-30 years) through year 15 (ages 33-45 years). Biomarkers of inflammation (high-sensitivity C-reactive protein), oxidative stress (superoxide dismutase, F2-isoprostanes), and endothelial dysfunction (soluble intercellular adhesion molecule 1, soluble P-selectin) were assessed at year 15. We conducted separate linear regression analyses with CES-D trajectory, CPD trajectory, and their interaction with each of the five biomarkers. Results The sample was 56% women, 47% black, and 40 years old on average at year 15. The CES-D trajectory by CPD trajectory interaction was not associated with any of the biomarkers (all p's >.01). Removing the interaction term, CES-D trajectory was associated with inflammation: higher levels of high-sensitivity C-reactive protein were observed in the subthreshold (β = 0.57, p =.004) and increasing depressive symptoms (β = 1.36, p <.001) trajectories compared with the no depression trajectory. CPD trajectory was associated with oxidative stress and endothelial dysfunction: compared with never smokers, heavy smokers had significantly higher levels of F2-isoprostanes (β = 6.20, p =.001), soluble intercellular adhesion molecule 1 (β = 24.98, p <.001), and soluble P-selectin (β = 2.91, p <.001). Conclusions Co-occurring depressive symptoms and smoking do not seem to synergistically convey risk for cardiovascular disease via processes of inflammation, oxidative stress, or endothelial dysfunction. Nonetheless, these results advance our understanding of the complex relationships between modifiable risk factors and chronic disease.

KW - Cardiovascular disease

KW - depression

KW - endothelial dysfunction

KW - inflammation

KW - oxidative stress

KW - smoking

UR - http://www.scopus.com/inward/record.url?scp=85065464163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065464163&partnerID=8YFLogxK

U2 - 10.1097/PSY.0000000000000667

DO - 10.1097/PSY.0000000000000667

M3 - Article

VL - 81

SP - 372

EP - 379

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 4

ER -